Amrutanjan Health Care Limited

rs,

ra (E) Mumbai 400 051 ISIN: INEO98F01031 Department of Corporate Services 1st Floor, P.J. Towers, Dalal Street, Mumbai 400 001 February 11, 2021 Symbol : AMRUTANJAN Scrip Code: 590006 Dear

18.10%

Profit Before Tax 68.19 222.72 23.82 YTD Dec'20 YTD Dec'19 YTD Dec'20 YTD Dec'19 Growth: 18.10% Gross Sales - E Comm. 3.41 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 - Growth:

186.27%

Gross Sales - E Comm. 3.41 4.00 3.50 3.00 2.50 2.00 1.50 1.00 0.50 - Growth: 186.27% Profit After Tax 50.96 1.23 17.19 YTD Dec'20 YTD Dec'19 Growth: 177.24% YTD Dec'20 YTD

177.24%

0.50 - Growth: 186.27% Profit After Tax 50.96 1.23 17.19 YTD Dec'20 YTD Dec'19 Growth: 177.24% YTD Dec'20 YTD Dec'19 Growth: 196.45% Investor Presentation | Quarter & Period Ended 31st Decem

196.45%

ax 50.96 1.23 17.19 YTD Dec'20 YTD Dec'19 Growth: 177.24% YTD Dec'20 YTD Dec'19 Growth: 196.45% Investor Presentation | Quarter & Period Ended 31st December 2020 6 Financials – YTD Dec’20 – OT

22.09%

OTC Division (Rs. in Crores) Gross Sales - OTC 252.44 206.76 YTD Dec'20 YTD Dec'19 Growth: 22.09% Gross Sales - Comfy 39.62 32.56 YTD Dec'20 YTD Dec'19 Growth: 21.68% Costs: • OTC sales h

21.68%

0 YTD Dec'19 Growth: 22.09% Gross Sales - Comfy 39.62 32.56 YTD Dec'20 YTD Dec'19 Growth: 21.68% Costs: • OTC sales has grown by 22.09% for YTD Dec’20 even though in Q1 sales was affected due

331 basis point

prices including Menthol are lower when compared to YTD Dec’19. • Gross Margin has improved by 331 basis points when compared to YTD Dec’19. • Advertisement spend for YTD Dec’20 is at 16.22 cr against 27.14

31.34%

Division (Rs. in Crores) Gross Sales - Beverages 14.04 9.64 YTD Dec'20 YTD Dec'19 Growth: -31.34% Gross Sales - Electro Plus 6.04 4.09 YTD Dec'20 YTD Dec'19 Growth: 47.68% Costs: • Gross

47.68%

Dec'19 Growth: -31.34% Gross Sales - Electro Plus 6.04 4.09 YTD Dec'20 YTD Dec'19 Growth: 47.68% Costs: • Gross Margin has improved by 562 basis points when compared to YTD Dec’19 mainly due

562 basis point

lus 6.04 4.09 YTD Dec'20 YTD Dec'19 Growth: 47.68% Costs: • Gross Margin has improved by 562 basis points when compared to YTD Dec’19 mainly due to product mix. • Advertisement spends is at Rs.2.01 cr

Rs.2.01

asis points when compared to YTD Dec’19 mainly due to product mix. • Advertisement spends is at Rs.2.01 cr for YTD Dec’20 against Rs.0.68 cr for YTD Dec’19. • Business is continuing with cash & carry

Costs

2

We remain focused on executing our key priorities

1

Costs

• OTC sales has grown by 22.09% for YTD Dec’20 even though in Q1 sales was affected due to Covid 19 lockdown. • Key raw material prices including Menthol are lower when compared to YTD Dec’19. • Gross Margin has improved by 331 basis points when compared to YTD Dec’19. • Advertisement spend for YTD Dec’20 is at 16.22 cr against 27.14 cr for YTD Dec’19. Investor Presentation | Quarter & Period Ended 31st December 2020 7 Financials – YTD Dec’20 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 14.04 9.64 YTD Dec'20 YTD Dec'19 Growth: -31.34% Gross Sales - Electro Plus 6.04 4.09 YTD Dec'20 YTD Dec'19 Growth: 47.68%

Costs

• Gross Margin has improved by 562 basis points when compared to YTD Dec’19 mainly due to product mix. • Advertisement spends is at Rs.2.01 cr for YTD Dec’20 against Rs.0.68 cr for YTD Dec’19. • Business is continuing with cash & carry model for Fruitnik. Investor Presentation | Quarter & Period Ended 31st December 2020 8 Q3 FY21 Performance Investor Presentation | Quarter & Period Ended 31st December 2020 9 Financials – Q3 FY21 (Rs. in Crores) Profit Before Tax 28.14 Profit After Tax 20.99 12.60 9.49 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Growth: 21.67% Growth: 123.33% Growth: 121.18% Investor Presentation | Quarter & Period Ended 31st December 2020 10 Financials – Q3 FY21 (Rs. in Crores) Gross Sales - OTC 107.62 88.61 Gross Sales - Comfy 16.32 Gross Sales - Beverages 11.57 2.59 1.84 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Q3 FY21 Q3 FY20 Growth: 21.45% Growth: 41.05% Growth: 40.76% Investor Presentation | Quarter & Period Ended 31st December 2020 11 Way Forward Investor Presentation | Quarter & Per

We remain focused on executing our key priorities

• Complete Q4 with same growth momentum • Expand distribution • Strengthen Beverage business • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter & Period Ended 31st December 2020 13 Investor Presentation | Quarter & Period Ended 31st December 2020 14